Liver cancer
Results
Phase 3
This trial looked at a drug called ADI-PEG 20 for liver cancer that had got worse after treatment.
It was open to people with a type of liver cancer called hepatocellular carcinoma (HCC). And who had treatment that reached the whole body (.
This trial was open for people to join between 2011 and 2015. These results were published in 2018.
Recruitment start: 26 July 2011
Recruitment end: 3 February 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr David Propper
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Polaris Group
Last reviewed: 16 Mar 2020
CRUK internal database number: 9277
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
